These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 27215754)

  • 1. [Psoriasis in special localizations].
    Schmieder A; Peitsch WK
    Hautarzt; 2016 Jun; 67(6):454-63. PubMed ID: 27215754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas.
    Wozel G
    Clin Dermatol; 2008; 26(5):448-59. PubMed ID: 18755363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2).
    Rich P; Gooderham M; Bachelez H; Goncalves J; Day RM; Chen R; Crowley J
    J Am Acad Dermatol; 2016 Jan; 74(1):134-42. PubMed ID: 26549249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer trends in the management of psoriasis at difficult to treat locations: scalp, palmoplantar disease and nails.
    Handa S
    Indian J Dermatol Venereol Leprol; 2010; 76(6):634-44. PubMed ID: 21079306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis of the scalp. Diagnosis and management.
    van de Kerkhof PC; Franssen ME
    Am J Clin Dermatol; 2001; 2(3):159-65. PubMed ID: 11705093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of Nail and Scalp Psoriasis Using Apremilast in Patients With Chronic Psoriasis: Phase 2b and 3, 52-Week Randomized, Placebo-Controlled Trial Results.
    Nguyen CM; Leon A; Danesh M; Beroukhim K; Wu JJ; Koo J
    J Drugs Dermatol; 2016 Mar; 15(3):272-6. PubMed ID: 26954311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis.
    Langley RG; Rich P; Menter A; Krueger G; Goldblum O; Dutronc Y; Zhu B; Wei H; Cameron GS; Heffernan MP
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1763-70. PubMed ID: 25693783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of adalimumab in the treatment of scalp and nail affection in patients with moderate to severe plaque psoriasis in routine clinical practice.
    Khobzey K; Liskova I; Szegedi A; Pavlovsky L; Lunder T; Kingo K; Miljković J; Péč J; Bohinc M; Hojnik M
    Acta Dermatovenerol Alp Pannonica Adriat; 2017 Mar; 26(1):11-14. PubMed ID: 28352929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensus.
    Rigopoulos D; Baran R; Chiheb S; Daniel CR; Di Chiacchio N; Gregoriou S; Grover C; Haneke E; Iorizzo M; Pasch M; Piraccini BM; Rich P; Richert B; Rompoti N; Rubin AI; Singal A; Starace M; Tosti A; Triantafyllopoulou I; Zaiac M
    J Am Acad Dermatol; 2019 Jul; 81(1):228-240. PubMed ID: 30731172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based guidelines of the spanish psoriasis group on the use of biologic therapy in patients with psoriasis in difficult-to-treat sites (nails, scalp, palms, and soles).
    Sánchez-Regaña M; Aldunce Soto MJ; Belinchón Romero I; Ribera Pibernat M; Lafuente-Urrez RF; Carrascosa Carrillo JM; Ferrándiz Foraster C; Puig Sanz L; Daudén Tello E; Vidal Sarró D; Ruiz-Villaverde R; Fonseca Capdevila E; Rodríguez Cerdeira MC; Alsina Gibert MM; Herrera Acosta E; Marrón Moya SE;
    Actas Dermosifiliogr; 2014 Dec; 105(10):923-34. PubMed ID: 24852726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nail Psoriasis: An Updated Review and Expert Opinion on Available Treatments, Including Biologics.
    Bardazzi F; Starace M; Bruni F; Magnano M; Piraccini BM; Alessandrini A
    Acta Derm Venereol; 2019 May; 99(6):516-523. PubMed ID: 30521057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory nail conditions. Part 1: nail changes in psoriasis.
    Yesudian PD; de Berker DAR
    Clin Exp Dermatol; 2021 Jan; 46(1):9-15. PubMed ID: 33220008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective treatment of severe nail psoriasis using topical calcipotriol with betamethasone dipropionate gel.
    Tan ES; Oon HH
    Indian J Dermatol Venereol Leprol; 2016; 82(3):345-7. PubMed ID: 27088952
    [No Abstract]   [Full Text] [Related]  

  • 14. Scalp and nail psoriasis.
    Lane-Brown MM
    Med J Aust; 1980 Jan; 1(2):82. PubMed ID: 7360098
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of Scalp Psoriasis.
    Ghafoor R; Patil A; Yamauchi P; Weinberg J; Kircik L; Grabbe S; Goldust M
    J Drugs Dermatol; 2022 Aug; 21(8):833-837. PubMed ID: 35946971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are topical keratolytic agents needed in the treatment of scalp psoriasis?
    Shokeen D; O'Neill JL; Taheri A; Feldman SR
    Dermatol Online J; 2014 Mar; 20(3):. PubMed ID: 24656276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical treatments for scalp psoriasis: summary of a Cochrane Systematic Review.
    Schlager JG; Rosumeck S; Werner RN; Jacobs A; Schmitt J; Schlager C; Nast A
    Br J Dermatol; 2017 Mar; 176(3):604-614. PubMed ID: 27312814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problem sites: scalp, palm and sole, and nail.
    Larko O
    Dermatol Clin; 1995 Oct; 13(4):771-7. PubMed ID: 8785882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis.
    Kin KC; Hill D; Feldman SR
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):789-97. PubMed ID: 27089906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psoriasis capitis and seborrhoic eczema of scalp diseases].
    Sticherling M
    Hautarzt; 2017 Jun; 68(6):457-465. PubMed ID: 28567508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.